These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21312101)

  • 1. Cytogenetics analysis.
    Sandberg AA; Chen Z
    Methods Mol Med; 2001; 55():3-18. PubMed ID: 21312101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal image analysis of chronic leukemic lymphoproliferative disorders and the hypothesis of "single" and "multiple" programmed stops in the development of typical and atypical forms of leukemias and lymphomas.
    Kardum-Skelin I; Puskarić BJ; Radić-Kristo D; Jaksić O; Kardum M; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):367-76. PubMed ID: 20698104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis.
    Hussein K; Ketterling RP; Hulshizer RL; Kuffel DG; Wiktor AE; Hanson CA; Tefferi A; Van Dyke DL
    Eur J Haematol; 2008 Apr; 80(4):318-21. PubMed ID: 18088399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies.
    Hussein K; Ketterling RP; Dewald GW; Van Dyke DL; Mesa R; Hanson CA; Tefferi A
    Leuk Res; 2008 Oct; 32(10):1597-600. PubMed ID: 18241918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of cytogenetics in neoplastic diseases.
    Sandberg AA
    Crit Rev Clin Lab Sci; 1985; 22(3):219-74. PubMed ID: 3899509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
    Cherry AM; Slovak ML; Campbell LJ; Chun K; Eclache V; Haase D; Haferlach C; Hildebrandt B; Iqbal AM; Jhanwar SC; Ohyashiki K; Sole F; Vandenberghe P; VanDyke DL; Zhang Y; Dewald GW
    Leuk Res; 2012 Jul; 36(7):832-40. PubMed ID: 22537394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples.
    Xu Y; McKenna RW; Asplund SL; Kroft SH
    Am J Clin Pathol; 2002 Nov; 118(5):758-64. PubMed ID: 12428797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia.
    Glassman AB; Harper-Allen EA; Hayes KJ; Hopwood VL; Gutterman EE; Zagryn SP
    Ann Clin Lab Sci; 1998; 28(1):24-9. PubMed ID: 9512781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
    Fugazza G; Miglino M; Bruzzone R; Quintino S; Gatti AM; Grasso R; Gobbi M; Frassoni F; Sessarego M
    J Exp Clin Cancer Res; 2004 Jun; 23(2):295-9. PubMed ID: 15354415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.
    Bilhou-Nabera C; Bernard P; Marit G; Viard F; Gharbi MJ; Wen Z; Lacombe F; Broustet A; Reiffers J
    Bone Marrow Transplant; 1992 Apr; 9(4):263-8. PubMed ID: 1600414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
    Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
    Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.